A clinical trial to learn how an investigational drug (vimseltinib) is absorbed, distributed, broken down, and removed from the body when given to people with liver problems

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-503415-15-00

Acronym

DCC-3014-01-004

Enrollment

Registered

2023-09-15

Start date

2023-12-21

Completion date

2025-12-05

Last updated

2023-12-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant Solid Tumors (MST), Tenosynovial Giant Cell Tumor (TGCT)

None listed

Sex/Gender

All

Age

18 Years to No maximum

Hungary

None listed

Source: EU CTIS · Data processed: Feb 4, 2026